Krsnaa Diagnostics Ltd.
NSE: KRSNAA · Healthcare Service Provider
Snapshot
Unlock Krsnaa Diagnostics Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Krsnaa Diagnostics Limited provides a comprehensive range of technology-enabled diagnostic services, including radiology, pathology, and tele-radiology. The company serves public and private hospitals, medical colleges, and community health centres across India.
Business Model
The company operates through a network of diagnostic centres, providing essential medical testing services to both public and private healthcare institutions.
- Diagnostic centres:1,801
- Geographic presence:13 states
Growth Outlook
Growth is driven by the expansion of its diagnostic centre network and the increasing demand for outsourced diagnostic services within the Indian healthcare ecosystem.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or pricing regulations could impact profit margins.
- Operational Risk. The company relies on maintaining high-quality standards across a large, geographically dispersed network of diagnostic centres.
- Competition. The diagnostic services market in India is highly fragmented and competitive, which may exert pressure on pricing.
- Dependency on Public-Private Partnerships. A significant portion of the business model relies on contracts with government institutions, which are subject to renewal and policy shifts.
Start your research today
Unlock AI insights, financials, peers and live data on Krsnaa Diagnostics Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹815 Cr
TTM · consolidated
NET PROFIT
₹97 Cr
TTM · consolidated
EPS
₹30.06
TTM · consolidated
RETURN ON EQUITY
10.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
13.3%
TTM · consolidated
P/E
18.6x
Q1 FY27 · consolidated
EV/EBITDA
8.8x
Q1 FY27 · consolidated
EBITDA MARGIN
32.5%
TTM · consolidated
NET PROFIT MARGIN
7.0%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.5x
Q1 FY27 · consolidated
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,817 Cr | 18.63 | 8.75 | 10.2% | 32.5% | 10.5% | 13.3% | -32.6% |
Nephrocare Health ServicesNEPHROPLUS | ₹6,994 Cr | — | — | — | 23.0% | — | — | — |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,731 Cr | 47.49 | 16.34 | 22.5% | 32.7% | 15.8% | 18.6% | +9.8% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,253 Cr | 20.88 | 14.79 | 41.9% | 58.0% | 21.2% | 26.3% | +1.9% |
One Global Service Provider LimitedONEGLOBAL | ₹1,060 Cr | — | — | — | 19.0% | — | — | +107.5% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹847 Cr | — | — | — | 36.0% | — | — | — |
As of Q1 FY27
Financials
Krsnaa Diagnostics Ltd.
NSE: KRSNAA · Healthcare Service Provider
Snapshot
Unlock Krsnaa Diagnostics Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Krsnaa Diagnostics Limited provides a comprehensive range of technology-enabled diagnostic services, including radiology, pathology, and tele-radiology. The company serves public and private hospitals, medical colleges, and community health centres across India.
Business Model
The company operates through a network of diagnostic centres, providing essential medical testing services to both public and private healthcare institutions.
- Diagnostic centres:1,801
- Geographic presence:13 states
Growth Outlook
Growth is driven by the expansion of its diagnostic centre network and the increasing demand for outsourced diagnostic services within the Indian healthcare ecosystem.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or pricing regulations could impact profit margins.
- Operational Risk. The company relies on maintaining high-quality standards across a large, geographically dispersed network of diagnostic centres.
- Competition. The diagnostic services market in India is highly fragmented and competitive, which may exert pressure on pricing.
- Dependency on Public-Private Partnerships. A significant portion of the business model relies on contracts with government institutions, which are subject to renewal and policy shifts.
Start your research today
Unlock AI insights, financials, peers and live data on Krsnaa Diagnostics Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹815 Cr
TTM · consolidated
NET PROFIT
₹97 Cr
TTM · consolidated
EPS
₹30.06
TTM · consolidated
RETURN ON EQUITY
10.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
13.3%
TTM · consolidated
P/E
18.6x
Q1 FY27 · consolidated
EV/EBITDA
8.8x
Q1 FY27 · consolidated
EBITDA MARGIN
32.5%
TTM · consolidated
NET PROFIT MARGIN
7.0%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.5x
Q1 FY27 · consolidated
Peers · Healthcare Service Provider
As of Q1 FY27